Neelam, Ameera, and Anand Kanaki. “Efficacy and Safety of Remogliflozin Etabonate in Type 2 Diabetes Mellitus Patients in a Tertiary Care Hospital”. International Journal of Basic & Clinical Pharmacology 10, no. 4 (March 22, 2021): 353–356. Accessed January 31, 2026. https://www.ijbcp.com/index.php/ijbcp/article/view/4535.